Probiotics for induction of remission in ulcerative colitis

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Mallon, P ^b   McKay, D ^b   Kirk, S ^b   Gardiner, Keith ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Colitis, ulcerative *diet therapy ; Humans; Probiotics *therapeutic use ; Randomized controlled trials as topic; Remission induction

Indexed keywords

CORTICOSTEROID; FRUCTOSE OLIGOSACCHARIDE; INULIN; MESALAZINE; PLACEBO; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE;

ABDOMINAL PAIN; BLOATING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; HEADACHE; HUMAN; MOUTH ULCER; NAUSEA; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW; ULCERATIVE COLITIS;

EID: 44949212835     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005573.pub2     Document Type: Review

References (22)

1. Furrie 2005 {published data only} Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA, et al.Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005;54(2):242-9.
2. Kato 2004 {published data only} Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, et al.Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 2004;20(10):1133-41.
3. Rembacken 1999 {published data only} Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Eshcherichia coli versusmesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet 1999;354(9179):635-9.
4. Tursi 2004 {published data only} Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, Gigliobianco A. Low dose balsalazide plus a high potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 2004;10(11):126-31.
5. Bibiloni 2005 Biblioni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, et al.VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005;100(7):1539-46.
6. Cui 2004 Cui HH, Chen CL, Wang JD, Yang YJ, Cun Y, Wu JB, et al.Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 2004;10(10):1521-5.
7. Gionchetti 2000 Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al.Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119(2):305-9.
8. Gionchetti 2003 Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, et al.Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003;124(5):1202-9.
9. Guslandi 2003 Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 2003;15(6):697-8.
10. Ishikawa 2003 Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003;22(1):56-63.
11. Kruis 1997 Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation andmesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997;11(5):853-8.
12. Kruis 2004 Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, et al.Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004;53(11):1617-23.
13. Veereman-Wauters 03 Veereman-Wauters G. Pouchitis prevention with probiotics. J Pediatr Gastroenterol 2003;37(5):636.
14. Bernet 1994 Bernet MF, Brassart D, Nesser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994;35(4):483-9.
15. Coconnier 1993 Coconnier MH, Bernet MF, Kernesis S, Chauviere G, Fourniat J, Servin AL. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett 1993;110(3):299-305.
16. Delia 2002 Delia P, Sansotta G, Donato V, Messina G, Frosina P, Pergolizzi S, et al.Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol 2002;97(8):2150-2.
17. Fabia 1993 Fabia R, Ar'Rajab A, Johannsson ML, Willen R, Andersson R, Molin G, et al.The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand J Gastroenterol 1993;28(2):155-62.
18. Fuller 1989 Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66(5):365-78.
19. Isolauri 1991 Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88(1):90-7.
20. Madsen 1999 Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999;116(5):1107-14.
21. Perdigon 1995 Perdigon G, Alvarez S, Rachid M, Aguero G, Gobbato N. Immune system stimulation by probiotics. J Dairy Sci 1995;78(7):1597-606.
22. Schultz 2002 Schultz M, Veltkamp C, Dieleman LA, Grenther WB, Wyrick PB, Tonkonogy SL, et al.Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 2002;8(2):71-80.